Newstral
Article
The New York Times on 2018-07-11 14:53
Pfizer to Defer Some Drug Price Increases After Trump Criticism
Related news
Under pressure from Trump, Pfizer delays drug price increasesSan Jose Mercury News
Pfizer buckles under pressure from Trump, delays drug price increasesWashington Post
Britain fines Pfizer record $107m for huge drug price hiketimesofmalta.com
Donald Trump Shames ‘Pfizer & Others’ over Drug Price Hikesbreitbart.com
Pfizer fined $107M for massive drug price hikeNew York Post
Pfizer ramped up epilepsy drug price by 2,600%timesofmalta.com
Pfizer Reverses Drug Price Hikes After Call with Trump and HHS Secretarybreitbart.com
Britain fines Pfizer record $107-million for huge drug price hikeThe Globe and Mail
- FPfizer accused of inflating drug priceft.com
Pfizer reneged on price increases after drawing ire of Trumpbizjournals.com
- FNovartis joins Pfizer in shelving US price increasesft.com
Pfizer to Roll Back Price Increases After Trump Criticismwsj.com
- BDrug-Price Increases Show Business as Usual Despite Public Pressurebarrons.com
Trump says drug maker Pfizer ‘rolling back price hikes’The Findlay Courier
- WPfizer fined record $107M for 2600% drug price hikewhitecourtpress.com
Trump says drug maker Pfizer 'rolling back price hikes'thenewstribune.com
Pfizer CEO rallies staff to fight Democrats’ drug price negotiationPOLITICO
- FPharmaceuticals: J&J prepares for drug price war with Pfizerft.com